Clinical Trial Update: Clinical and Pharmacokinetic Trial of Intra-Abdominal Irinotecan [Phase 1]

View source ↗

Summary

A Phase 1 clinical and pharmacokinetic study evaluating intraperitoneal irinotecan in patients with adenocarcinoma and gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma
• Gastric Cancer

Drugs mentioned

• Camptosar (irinotecan)

Snippet

Sponsor: University of Southern California | Conditions: Adenocarcinoma, Gastric Cancer | Phase 1 | Status: COMPLETED